New Blog Posts:

  • Cannabis In Canada – Sweeping Changes — by Brian Wagner
  • Quality Assurance: An Important Contributor to Value Creation — by Dr. Gina Stetsko
  • Winding Down 2017 With Tremendous Gratitude— by Ali Ardakani

Upcoming Events:

  • LifeSciences BC Blakes Breakfast Speaking Event on the Emerging Cannabis Industry (December 7, 2017 — Vancouver, BC)
  • LifeSciences BC MedTech Holiday Social (December 13, 2017 — Vancouver, BC)
  • A Guide to Navigate J.P. Morgan 36th Annual Healthcare Conference 2018 (January 8-11, 2018 — San Francisco, CA)

New Blog Posts

Cannabis In Canada – Sweeping Changes
Brian Wagner
Lead Cannabis Advisor

On November 22nd, Health Canada announced their proposed new legalization framework for cannabis in Canada – full proposal is found here – and which is now launching Canada to the forefront of the global cannabis market. I’ve seen many regulatory adjustments and changes to cannabis in the last decade, but nothing quite like this. Most of us are still waking up with a “regulatory hangover” and trying to process all of the changes. As the founder and CEO of the world’s largest and most professional cannabis compliance firm, I’m writing this article to provide my insights on where cannabis is headed. Because this is a game changer.

Continue reading >
Quality Assurance: An Important Contributor to Value Creation
Gina G. Stetsko, PhD
Head of Product Development & Manufacturing
Novateur Ventures

For most start-up pharma companies the drive to the next fundraising milestone and value inflection point consumes most of their planning. Sometimes, however, some of the details “behind the scenes” can be deprioritized, such as a designated person responsible for quality assurance, a preliminary quality system and quality procedures.

From a regulatory perspective a quality assurance function ensures compliance with regulatory guidances and the integrity of the data generated by all parties involved so it is suitable for regulatory submission or for review by potential future partners.

Continue reading >
Winding Down 2017 With Tremendous Gratitude
Ali Ardakani
Managing Director
Novateur Ventures

As we approach the end of 2017, we look back with tremendous gratitude for the many friends and supporters of Novateur, especially for our valued clients, whom we consider our partners.

We had a great year and grew our practice in substantial ways in every possible metric. We worked with over 30 companies and investment groups conducting due diligence and providing product and project development advisory. We completed over 120 projects. Our clients raised over $100 M in capital, including one that successfully became public on a US stock exchange. Several companies also completed partnerships with larger pharma clients.

We believe Novateur is the solution for the “talent” challenge in Canada and other geographies where there is dearth of seasoned development and execution expertise and lack of a track record.

Continue reading >

Client Testimonials

"The Novateur Ventures’ team guided us to the next level, bringing knowledge, experience and credibility to our team. Simply put, it was like having a world class scientific advisory board, BD team, drug development team simultaneously!"

— Frédéric Leduc, PhD
CEO & Co-Founder

"Novateur’s experience in tackling difficult manufacturing problems is unparalleled, they bring a wealth of wisdom and enthusiasm to the team. It has been a pleasure working with Novateur."

— Amanda Malone, PhD
Chief Scientific Officer

Upcoming Events: Don't Miss Out

LifeSciences BC Blakes Breakfast Speaking Event
on the Emerging Cannabis Industry

December 7, 2017 — Vancouver, BC

LifeSciences BC have brought together a panel of industry experts to discuss the issues affecting the emerging cannabis industry. The panel members will address public and private finance for cannabis companies and regulatory matters affecting the industry.

Panel members:

  • Jamie Brown, Vice-Chairman, Managing Director – Canaccord Genuity 
  • Sam Znaimer, Founder & CEO – Trimble Hill, Founder – Locarno & Member of the Limited Partner Advisory Committee – Version One 
  • Chris Nyberg, Associate – Blakes 

There will also be company presentations by:

  • Emerald Health – Chris Wagner – CEO
  • Anandia – Jonathan Page – CEO
  • Tilray – Woody Pastorius – COO
More information & registration >
LifeSciences BC MedTech Holiday Social

December 13, 2017 — Vancouver, BC

Come and meet your peers in Metro Vancouver’s medical technology industry and join LifeSciences BC members for a festive evening of networking and socializing. The ticket includes a burger and a choice of one: beer, glass of house red or white wine or a well highball drink.
More information & registration >
J.P. Morgan 36th Annual Healthcare Conference 2018

January 8-11, 2018 — San Francisco, CA

The J.P. Morgan Healthcare Conference continues the tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2018, there are more than 400 companies expected, both public and private, to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting.
More information >
Ultimate List of J.P. Morgan Healthcare Conference 2018 Satellites

More Articles

How to Climb the Life Sciences Mountain

The challenges facing the life sciences sector are well documented, even if there is some debate about which ones are most urgent. From cost and pricing pressures to regulatory compliance, the barriers to success can be significant.

As a result, the mantra “fail it fast” has become a truism. The journey to commercialization is long and expensive; if something isn’t going to succeed, it’s better to know early so that scientists and investors can move on to the next project.

But what about innovations that fail because the teams behind them were missing critical knowledge? How many promising products would live to see the market if their journey was guided by experts who had travelled the route before?

Read in Insights magazine >
Download Novateur article >
Get in Touch
Download Novateur presentation >

Call Us
+1 844 200 6682 (NOVA)
Toll Free USA & Canada

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Novateur Ventures Inc. · 1055 West Georgia Street · Suite 2100 · Vancouver, BC V6E 3P3 · Canada

Email Marketing Powered by Mailchimp